[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 399 9500", "website": "https://www.tscan.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT) is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also advanced TS-102 into IND-enabling activities. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors. It has collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 208, "companyOfficers": [{"maxAge": 1, "name": "Dr. Gavin  MacBeath Ph.D.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1025727, "exercisedValue": 0, "unexercisedValue": 207573}, {"maxAge": 1, "name": "Mr. Jason A. Amello CPA", "age": 56, "title": "CFO & Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 767342, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chrystal U. Louis M.D., M.P.H.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 550125, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen J. Elledge Ph.D.", "title": "Co-Founder & Chairman of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tomasz  Kula Ph.D.", "title": "Co-Founder & Member of Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leiden  Dworak M.B.A.", "age": 40, "title": "Principal Accounting Officer", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Justin  McCue Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zoran  Zdraveski J.D., Ph.D.", "age": 54, "title": "Chief Legal & Strategy Officer and Company Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 657200, "exercisedValue": 0, "unexercisedValue": 85247}, {"maxAge": 1, "name": "Ms. Ann  Hargraves", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shrikanta  Chattopadhyay M.D.", "title": "Senior VP & Head of Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.16, "open": 1.16, "dayLow": 1.07, "dayHigh": 1.16, "regularMarketPreviousClose": 1.16, "regularMarketOpen": 1.16, "regularMarketDayLow": 1.07, "regularMarketDayHigh": 1.16, "payoutRatio": 0.0, "beta": 0.999, "forwardPE": -0.8449613, "volume": 720544, "regularMarketVolume": 720544, "averageVolume": 551620, "averageVolume10days": 1218060, "averageDailyVolume10Day": 1218060, "bid": 1.06, "ask": 1.12, "bidSize": 4, "askSize": 4, "marketCap": 61855312, "fiftyTwoWeekLow": 1.02, "fiftyTwoWeekHigh": 5.92, "allTimeHigh": 14.71, "allTimeLow": 1.02, "priceToSalesTrailing12Months": 8.885981, "fiftyDayAverage": 1.9071, "twoHundredDayAverage": 1.75225, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -59489688, "profitMargins": 0.0, "floatShares": 44031335, "sharesOutstanding": 52471405, "sharesShort": 1675616, "sharesShortPriorMonth": 1722543, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0295, "heldPercentInsiders": 0.00228, "heldPercentInstitutions": 0.76171, "shortRatio": 2.74, "shortPercentOfFloat": 0.0359, "impliedSharesOutstanding": 56747993, "bookValue": 3.114, "priceToBook": 0.35003212, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -136775008, "trailingEps": -1.1, "forwardEps": -1.29, "enterpriseToRevenue": -8.546, "enterpriseToEbitda": 0.422, "52WeekChange": -0.8087719, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 1.09, "targetHighPrice": 10.0, "targetLowPrice": 6.0, "targetMeanPrice": 8.4, "targetMedianPrice": 9.0, "recommendationMean": 1.71429, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 218044992, "totalCashPerShare": 3.842, "ebitda": -141123008, "totalDebt": 96700000, "quickRatio": 6.961, "currentRatio": 7.06, "totalRevenue": 6961000, "debtToEquity": 54.721, "revenuePerShare": 0.123, "returnOnAssets": -0.26773, "returnOnEquity": -0.63331, "grossProfits": -8573000, "freeCashflow": -82941872, "operatingCashflow": -126183000, "revenueGrowth": 4.739, "grossMargins": -1.23158, "ebitdaMargins": 0.0, "operatingMargins": -12.56599, "financialCurrency": "USD", "symbol": "TCRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "TScan Therapeutics, Inc.", "longName": "TScan Therapeutics, Inc.", "exchange": "NGM", "messageBoardId": "finmb_583057578", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "market": "us_market", "regularMarketChangePercent": -6.03448, "regularMarketPrice": 1.09, "fiftyDayAverageChange": -0.8170999, "fiftyDayAverageChangePercent": -0.42845154, "twoHundredDayAverageChange": -0.6622499, "twoHundredDayAverageChangePercent": -0.37794262, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-16", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1762559010, "regularMarketTime": 1762549200, "gmtOffSetMilliseconds": -18000000, "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626442200000, "postMarketChangePercent": 1.0275184, "postMarketPrice": 1.1012, "postMarketChange": 0.011199951, "regularMarketChange": -0.0699999, "regularMarketDayRange": "1.07 - 1.16", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 551620, "fiftyTwoWeekLowChange": 0.07000005, "fiftyTwoWeekLowChangePercent": 0.06862751, "fiftyTwoWeekRange": "1.02 - 5.92", "fiftyTwoWeekHighChange": -4.83, "fiftyTwoWeekHighChangePercent": -0.81587833, "fiftyTwoWeekChangePercent": -80.87719, "earningsTimestamp": 1755144000, "earningsTimestampStart": 1762954200, "earningsTimestampEnd": 1762954200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.1, "epsForward": -1.29, "epsCurrentYear": -1.26167, "priceEpsCurrentYear": -0.86393434, "displayName": "TScan Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]